BTPS-054 IGNOU Guess Paper 2026-27

BTPS-054 Guess Paper 2026-27: Term-End Exam (TEE) Preparation Guide

This structured guess paper aligns with the official IGNOU syllabus for BTPS-054, featuring chapter-wise question distribution and time management strategies derived from previous years' exam patterns (2017–2026). Focus on high-scoring topics and solved question trends to optimize your 3-hour exam performance.

Key Syllabus Blocks & Weightage (Past TEE Trends)

• Unit 1: Biotechnology Regulation and Legal Frameworks
  • Focus on Gene Therapy Regulations (India) and IPR in Biotechnology (20–25% weightage).
  • Expected questions: Case studies on DRDO/Biotech Regulatory Authority and ethical dilemmas in patenting.
• Unit 3: Gene Editing Technologies
  • CRISPR-Cas9 mechanisms and off-target effects (15–20% weightage).
  • Solve numericals on efficiency of gene editing tools from past papers (e.g., 2020 Dec session).
• Unit 5: Safety Protocols in Biotechnology Labs
  • Biosafety Level (BSL) classifications and waste disposal protocols (10–15% weightage).
  • Short-answer questions on SOP for recombinant DNA handling (common in June sessions).
• Unit 7: Biotechnology and Environmental Sustainability
  • Focus on bioremediation case studies and carbon sequestration via bioengineering (10–12% weightage).
  • Expect 1–2 descriptive questions on ethical implications of GM crops.

Exam Time Management Tips (3-Hour Strategy)

• Allocate 45 minutes for reading the question paper and identifying high-scoring units (e.g., Units 1 and 3).
• Spend 1 hour on numerical problems (e.g., CRISPR efficiency calculations) and 1 hour 15 minutes on descriptive answers (e.g., regulatory frameworks).
• Leave 15 minutes for review, cross-checking diagrams (e.g., BSL workflows) and spellings.

Subject-Specific FAQs

Yes. Numerical problems on risk assessment in gene therapy (Unit 1) and CRISPR efficiency (Unit 3) appear consistently. Practice solved examples from 2018–2025 sessions.

Use case studies (e.g., Indian Council of Medical Research regulations) and real-world examples (e.g., CAR-T cell therapy approvals) to demonstrate understanding. Avoid generic definitions.